News

Nanorx founder Dr Raghavan to present Metadichol’s tuberculosis treatment effectiveness at Infectious Diseases conference

Metadichol is a nano emulsion made out of a food-based ingredient, created by Nanorx Inc, which has been found to prevent and treat tuberculosis.

May 13, 2019

By : Team ABLE

BIO, NIH to hold Fifth Innovation Zone Exhibit at 2019 BIO International Convention

The Small Business Innovation Research (SBIR)-funded early-stage biomedical companies featured at the zone will showcasebiotechnology breakthroughs at BIO 2019 International Convention.

May 10, 2019

By : Team ABLE

Takeda simplifies portfolio and accelerates deleveraging through two divestitures

Takeda has agreed to Sell Xiidra to Novartis for up to $5.3 billion and also divest TachoSil to Ethicon for approximately $400 million

May 10, 2019

By : Team ABLE

Gilead Sciences and Goldfinch Bio collaborate to develop therapies for kidney disease

Under the multi-year collaboration, Gilead has exclusive options to license worldwide rights to certain products directed toward targets emerging from Goldfinch’s proprietary Kidney Genome Atlas.

May 10, 2019

By : Team ABE

AlgaEnergy appoints Debabrata Sarkar as Vice President, Asia Pacificand Dr. Lokesh Singh as India Country Manager

AlgaEnergy is a biotechnology-based company specialized in the science of microalgae. Owing to its expansion plans, the company has appointed Debabrata Sarkar as Vice President, Asia Pacific and Dr Lokesh Singh as India Country Manager.

May 09, 2019

By : Team ABLE